Compare BVS & APOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | APOG |
|---|---|---|
| Founded | 2011 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.8M | 766.1M |
| IPO Year | 2016 | 1994 |
| Metric | BVS | APOG |
|---|---|---|
| Price | $8.70 | $37.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $14.00 | ★ $47.00 |
| AVG Volume (30 Days) | ★ 671.5K | 147.0K |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.03% |
| EPS Growth | ★ 163.46 | N/A |
| EPS | 0.04 | ★ 2.52 |
| Revenue | $568,087,000.00 | ★ $1,404,733,000.00 |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $7.06 | $2.07 |
| P/E Ratio | $213.75 | ★ $14.81 |
| Revenue Growth | N/A | ★ 3.21 |
| 52 Week Low | $5.81 | $30.75 |
| 52 Week High | $11.25 | $46.14 |
| Indicator | BVS | APOG |
|---|---|---|
| Relative Strength Index (RSI) | 40.09 | 55.17 |
| Support Level | $8.55 | $36.94 |
| Resistance Level | $9.24 | $37.97 |
| Average True Range (ATR) | 0.57 | 1.22 |
| MACD | -0.18 | 0.21 |
| Stochastic Oscillator | 28.21 | 68.61 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company geographically operates in the United States, Canada, and Brazil, with the majority revenue generated from the United States.